Trinity Biotech (TRIB) Assets Growth (5y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.21% |
| Jun 30, 2025 | -5.00% |
| Dec 31, 2024 | -4.65% |
| Sep 30, 2024 | -10.87% |
| Jun 30, 2024 | -11.29% |
| Mar 31, 2024 | -12.16% |
| Dec 31, 2023 | -17.08% |
| Sep 30, 2023 | -19.08% |
| Jun 30, 2023 | -18.02% |
| Mar 31, 2023 | -14.08% |
| Dec 31, 2022 | -13.75% |
| Sep 30, 2022 | -16.74% |
| Jun 30, 2022 | -15.23% |
| Mar 31, 2022 | -15.42% |
| Dec 31, 2021 | -13.78% |
| Sep 30, 2021 | -19.38% |
| Jun 30, 2021 | -19.00% |
| Mar 31, 2021 | -17.70% |
| Dec 31, 2020 | -18.33% |
| Sep 30, 2020 | -17.47% |
| Jun 30, 2020 | -18.58% |
| Mar 31, 2020 | -12.15% |
| Dec 31, 2019 | -11.60% |
| Sep 30, 2019 | -6.07% |
| Jun 30, 2019 | -6.36% |
| Mar 31, 2019 | -5.49% |
| Dec 31, 2018 | -7.71% |
| Sep 30, 2018 | -3.83% |
| Jun 30, 2018 | -0.90% |
| Mar 31, 2018 | -0.87% |
| Dec 31, 2017 | -0.45% |
| Sep 30, 2017 | 5.19% |
| Jun 30, 2017 | 5.88% |
| Mar 31, 2017 | 6.14% |
| Dec 31, 2016 | 7.79% |
| Sep 30, 2016 | 16.29% |
| Jun 30, 2016 | 16.32% |
| Mar 31, 2016 | 16.80% |
| Dec 31, 2015 | 17.41% |
| Sep 30, 2015 | 17.60% |
| Jun 30, 2015 | 18.61% |
| Mar 31, 2015 | 13.28% |
| Dec 31, 2014 | 12.89% |
| Sep 30, 2014 | 12.70% |
| Jun 30, 2014 | 12.69% |
| Mar 31, 2014 | 12.91% |